Effect of Mammographic Screening From Age 40 Years on Breast Cancer Mortality

Published in Oncology  Journal Scan / Research · July 29, 2015

Effect of Mammographic Screening From Age 40 Years on Breast Cancer Mortality

The Lancet Oncology
 TAKE-HOME MESSAGE—This one speaks for itself but read carefully- there are large numbers here in the intervention and control group and NOTE the 50 year old group got MMG every three years after the initial negative, not every year. However this study was one which supported MMG yearly because of greater survival for the first ten years but then no real difference in survival for the remaining  years to year 17. There are confounding results elsewhere and differing study design which is why so far the US preventive Task Force is correct in not stating it is unequivocally true that annual MMG starting at age 40 for NORMAL risk patients will help. We KNOW it can hurt in terms of false positives and unneeded surgery and the psycho social issues as well. I personally believe , after a good long talk about the data , I will offer MMG annually at age 40  and urge  for insurance companies to cover it if the test is a result of a documented Dr patient dialogue

BACKGROUND

The Lancet Oncology

Effect of Mammographic Screening From Age 40 Years on Breast Cancer Mortality in the UK Age Trial at 17 Years’ Follow-Up: A Randomised Controlled Trial

Lancet Oncol 2015 Jul 20;[EPub Ahead of Print], SM Moss, C Wale, R Smith, A Evans, H Cuckle, SW Duffy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s